iTeos Therapeutics, Inc. (ITOS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 310.84M |
| Enterprise Value | 173.81M |
| P/E Ratio | -3.06 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 12.82 |
| Price/Book Ratio | 0.7 |
| Enterprise/Revenue | 8.9 |
| Enterprise/EBITDA | -2.56 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -3.84 |
| Operating Margin | -4.56 |
| Return On Assets | -0.2 |
| Return On Equity | -0.23 |
| Revenue | 35M |
| Revenue/Share | 0.86 |
| Gross Profit | 33.76M |
| EBITDA | -121.82M |
| Net Income | -134.41M |
| Diluted EPS | -3.32 |
| Total Cash | 515.43M |
| Total Cash/Share | 12.22 |
| Total Debt | 5.13M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 12.62 |
| Book Value Per Share | 14.58 |
| 52-Week Change | -0.59 |
| 52-Week High | 17.63 |
| 52-Week Low | 4.8 |
| Moving Average 50 Days | 10.13 |
| Moving Average 200 Days | 8.29 |
| Average Volume | 1.34M |
| Shares Outstanding | 44.21M |
| % Held by Institutions | 86.8 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |